Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with BCR::ABL1 digital PCR in chronic myeloid leukemia patients

Precise and reliable predictive parameters to accurately identify chronic myeloid leukemia (CML) patients who can successfully discontinue their tyrosine kinase inhibitor (TKI) treatment are lacking. One promising parameter is depth of molecular response measured by BCR::ABL1 digital PCR (dPCR). The...

Full description

Saved in:
Bibliographic Details
Main Authors: Kockerols, Camille (Author) , Valk, Peter J. M. (Author) , Janssen, Jeroen J. W. M. (Author) , Hogenbirk, Pauline (Author) , Cornelissen, Jan J. (Author) , Saußele, Susanne (Author) , Spiess, Birgit (Author) , Perusini, Maria Agustina (Author) , Kim, Dennis (Author) , Westerweel, Peter E. (Author)
Format: Article (Journal)
Language:English
Published: November 2024
In: European journal of haematology
Year: 2024, Volume: 113, Issue: 5, Pages: 606-613
ISSN:1600-0609
DOI:10.1111/ejh.14271
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1111/ejh.14271
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/ejh.14271
Get full text
Author Notes:Camille Kockerols, Peter J.M. Valk, Jeroen J.W.M. Janssen, Pauline Hogenbirk, Jan J. Cornelissen, Susanne Saussele, Birgit Spiess, Maria Agustina Perusini, Dennis Kim, Peter E. Westerweel

MARC

LEADER 00000caa a2200000 c 4500
001 1909449229
003 DE-627
005 20241205222549.0
007 cr uuu---uuuuu
008 241125s2024 xx |||||o 00| ||eng c
024 7 |a 10.1111/ejh.14271  |2 doi 
035 |a (DE-627)1909449229 
035 |a (DE-599)KXP1909449229 
035 |a (OCoLC)1475647967 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kockerols, Camille  |e VerfasserIn  |0 (DE-588)1349272728  |0 (DE-627)190944975X  |4 aut 
245 1 0 |a Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with BCR::ABL1 digital PCR in chronic myeloid leukemia patients  |c Camille Kockerols, Peter J.M. Valk, Jeroen J.W.M. Janssen, Pauline Hogenbirk, Jan J. Cornelissen, Susanne Saussele, Birgit Spiess, Maria Agustina Perusini, Dennis Kim, Peter E. Westerweel 
264 1 |c November 2024 
300 |b Illustrationen 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 12. Juli 2024 
500 |a Gesehen am 25.11.2024 
520 |a Precise and reliable predictive parameters to accurately identify chronic myeloid leukemia (CML) patients who can successfully discontinue their tyrosine kinase inhibitor (TKI) treatment are lacking. One promising parameter is depth of molecular response measured by BCR::ABL1 digital PCR (dPCR). The aim of this study was to validate a previously described prediction cutoff of 0.0023%IS and to assess the value of dPCR for treatment-free remission (TFR) prediction in relation to other clinical parameters. A droplet-based dPCR assay assessed BCR::ABL1 %IS prior to TKI discontinuation. The primary endpoint was molecular recurrence (MolR) by 36 months. A total of 186 patients from Canada, Germany, and the Netherlands were included. In patients with a first TKI discontinuation attempt (n = 163), a BCR::ABL1 dPCR < and ≥0.0023%IS had a MolR probability of 33% and 70%, respectively. Patients treated less than 6 years with a BCR::ABL1 dPCR <0.0023%IS had a MolR probability of 31%. After correction for treatment duration, both high dPCR value and the use of imatinib (vs. second-generation TKI) were significantly associated with a higher risk of MolR (HR of 3.66, 95%CI 2.06-6.51, p < .001; and 2.85, 95%CI 1.25-6.46, p = .013, respectively). BCR::ABL1 dPCR was not associated with TFR outcome after second TKI discontinuation, however, with the limitation of a small number of patients analyzed (n = 23). In conclusion, BCR::ABL1 digital PCR based on the cutoff of 0.0023%IS is a valuable predictive tool to identify CML patients with a high probability of TFR success after first TKI discontinuation, including patients treated for less than 6 years. 
650 4 |a BCR::ABL1 digital PCR 
650 4 |a chronic myeloid leukemia 
650 4 |a treatment-free remission 
650 4 |a tyrosine kinase inhibitor discontinuation 
700 1 |a Valk, Peter J. M.  |e VerfasserIn  |4 aut 
700 1 |a Janssen, Jeroen J. W. M.  |e VerfasserIn  |4 aut 
700 1 |a Hogenbirk, Pauline  |e VerfasserIn  |4 aut 
700 1 |a Cornelissen, Jan J.  |e VerfasserIn  |4 aut 
700 1 |a Saußele, Susanne  |d 1968-  |e VerfasserIn  |0 (DE-588)115839860  |0 (DE-627)69162786X  |0 (DE-576)29010694X  |4 aut 
700 1 |a Spiess, Birgit  |d 1972-  |e VerfasserIn  |0 (DE-588)1028287496  |0 (DE-627)730538699  |0 (DE-576)37578764X  |4 aut 
700 1 |a Perusini, Maria Agustina  |e VerfasserIn  |4 aut 
700 1 |a Kim, Dennis  |e VerfasserIn  |4 aut 
700 1 |a Westerweel, Peter E.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t European journal of haematology  |d Oxford : Wiley-Blackwell, 1987  |g 113(2024), 5, Seite 606-613  |h Online-Ressource  |w (DE-627)320983463  |w (DE-600)2027114-1  |w (DE-576)093888864  |x 1600-0609  |7 nnas  |a Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with BCR::ABL1 digital PCR in chronic myeloid leukemia patients 
773 1 8 |g volume:113  |g year:2024  |g number:5  |g pages:606-613  |g extent:8  |a Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with BCR::ABL1 digital PCR in chronic myeloid leukemia patients 
856 4 0 |u https://doi.org/10.1111/ejh.14271  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/ejh.14271  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20241125 
993 |a Article 
994 |a 2024 
998 |g 1028287496  |a Spiess, Birgit  |m 1028287496:Spiess, Birgit  |d 60000  |d 61200  |d 60000  |e 60000PS1028287496  |e 61200PS1028287496  |e 60000PS1028287496  |k 0/60000/  |k 1/60000/61200/  |k 0/60000/  |p 7 
998 |g 115839860  |a Saußele, Susanne  |m 115839860:Saußele, Susanne  |d 60000  |d 61200  |e 60000PS115839860  |e 61200PS115839860  |k 0/60000/  |k 1/60000/61200/  |p 6 
999 |a KXP-PPN1909449229  |e 4622116286 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"part":{"text":"113(2024), 5, Seite 606-613","volume":"113","extent":"8","year":"2024","issue":"5","pages":"606-613"},"pubHistory":["38.1987 -"],"language":["eng"],"recId":"320983463","disp":"Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with BCR::ABL1 digital PCR in chronic myeloid leukemia patientsEuropean journal of haematology","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 08.05.09"],"title":[{"title_sort":"European journal of haematology","title":"European journal of haematology"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["320983463"],"doi":["10.1111/(ISSN)1600-0609"],"zdb":["2027114-1"],"issn":["1600-0609"]},"origin":[{"publisherPlace":"Oxford ; Copenhagen ; Oxford [u.a.]","dateIssuedDisp":"1987-","dateIssuedKey":"1987","publisher":"Wiley-Blackwell ; Munksgaard ; Blackwell"}]}],"physDesc":[{"extent":"8 S.","noteIll":"Illustrationen"}],"id":{"eki":["1909449229"],"doi":["10.1111/ejh.14271"]},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"November 2024"}],"name":{"displayForm":["Camille Kockerols, Peter J.M. Valk, Jeroen J.W.M. Janssen, Pauline Hogenbirk, Jan J. Cornelissen, Susanne Saussele, Birgit Spiess, Maria Agustina Perusini, Dennis Kim, Peter E. Westerweel"]},"recId":"1909449229","language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Online veröffentlicht: 12. Juli 2024","Gesehen am 25.11.2024"],"title":[{"title_sort":"Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with BCR::ABL1 digital PCR in chronic myeloid leukemia patients","title":"Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with BCR::ABL1 digital PCR in chronic myeloid leukemia patients"}],"person":[{"family":"Kockerols","given":"Camille","roleDisplay":"VerfasserIn","display":"Kockerols, Camille","role":"aut"},{"display":"Valk, Peter J. M.","roleDisplay":"VerfasserIn","role":"aut","family":"Valk","given":"Peter J. M."},{"role":"aut","roleDisplay":"VerfasserIn","display":"Janssen, Jeroen J. W. M.","given":"Jeroen J. W. M.","family":"Janssen"},{"family":"Hogenbirk","given":"Pauline","display":"Hogenbirk, Pauline","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Cornelissen","given":"Jan J.","roleDisplay":"VerfasserIn","display":"Cornelissen, Jan J.","role":"aut"},{"given":"Susanne","family":"Saußele","role":"aut","display":"Saußele, Susanne","roleDisplay":"VerfasserIn"},{"given":"Birgit","family":"Spiess","role":"aut","display":"Spiess, Birgit","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Perusini, Maria Agustina","role":"aut","family":"Perusini","given":"Maria Agustina"},{"family":"Kim","given":"Dennis","display":"Kim, Dennis","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Peter E.","family":"Westerweel","role":"aut","display":"Westerweel, Peter E.","roleDisplay":"VerfasserIn"}]} 
SRT |a KOCKEROLSCPREDICTION2024